ATE238264T1 - Verwendung v0n 1,3,4,6-tetrahydroxy-helianthron und derivaten in der photodynamischen therapie und derivate - Google Patents

Verwendung v0n 1,3,4,6-tetrahydroxy-helianthron und derivaten in der photodynamischen therapie und derivate

Info

Publication number
ATE238264T1
ATE238264T1 AT98933874T AT98933874T ATE238264T1 AT E238264 T1 ATE238264 T1 AT E238264T1 AT 98933874 T AT98933874 T AT 98933874T AT 98933874 T AT98933874 T AT 98933874T AT E238264 T1 ATE238264 T1 AT E238264T1
Authority
AT
Austria
Prior art keywords
derivatives
tetrahydroxy
photodynamic therapy
helianthron
helianthrone
Prior art date
Application number
AT98933874T
Other languages
English (en)
Inventor
Yehuda Mazur
Gad Lavie
Original Assignee
Yeda Res & Dev
Univ New York
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yeda Res & Dev, Univ New York filed Critical Yeda Res & Dev
Application granted granted Critical
Publication of ATE238264T1 publication Critical patent/ATE238264T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C46/00—Preparation of quinones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C50/00—Quinones
    • C07C50/26—Quinones containing groups having oxygen atoms singly bound to carbon atoms
    • C07C50/36—Quinones containing groups having oxygen atoms singly bound to carbon atoms the quinoid structure being part of a condensed ring system having four or more rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C65/00—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C65/32—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing keto groups
    • C07C65/40—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing keto groups containing singly bound oxygen-containing groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/95—Esters of quinone carboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/02—Ortho- or ortho- and peri-condensed systems
    • C07C2603/54—Ortho- or ortho- and peri-condensed systems containing more than five condensed rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT98933874T 1997-07-31 1998-07-27 Verwendung v0n 1,3,4,6-tetrahydroxy-helianthron und derivaten in der photodynamischen therapie und derivate ATE238264T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IL12144097A IL121440A0 (en) 1997-07-31 1997-07-31 The use of 1,3,4,6-tetrahydroxy-helianthrone and its derivatives in photodynamic therapy and certain such novel derivatives
PCT/IL1998/000346 WO1999006347A1 (en) 1997-07-31 1998-07-27 The use of 1,3,4,6-tetrahydroxy-helianthrone and its derivatives in photodynamic therapy and certain such novel derivatives

Publications (1)

Publication Number Publication Date
ATE238264T1 true ATE238264T1 (de) 2003-05-15

Family

ID=11070450

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98933874T ATE238264T1 (de) 1997-07-31 1998-07-27 Verwendung v0n 1,3,4,6-tetrahydroxy-helianthron und derivaten in der photodynamischen therapie und derivate

Country Status (8)

Country Link
US (1) US6229048B1 (de)
EP (1) EP1001924B1 (de)
AT (1) ATE238264T1 (de)
AU (1) AU8355598A (de)
CA (1) CA2298820C (de)
DE (1) DE69813828T2 (de)
IL (1) IL121440A0 (de)
WO (1) WO1999006347A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6794518B1 (en) 1998-12-18 2004-09-21 Bristol-Myers Squibb Pharma Company Vitronectin receptor antagonist pharmaceuticals
DE60125048T2 (de) 2000-01-31 2007-07-12 New York University Polycyclische dianthrachinone als antikrebsmittel und antiangiogenesemittel
EP1296678A2 (de) * 2000-06-21 2003-04-02 Bristol-Myers Squibb Pharma Company Arzneimittel mit vitronektin-rezeptor-antagonistischer wirkung zur anwendung in der kombinationstherapie
EP1379274A4 (de) * 2001-03-23 2006-02-15 Univ Texas Verfahren zur hemmung von angiogenese, tumorwachstum und metastasen mit voll humanem anti-il8 und anti-muc18 bei diversen tumortypen
US6838074B2 (en) 2001-08-08 2005-01-04 Bristol-Myers Squibb Company Simultaneous imaging of cardiac perfusion and a vitronectin receptor targeted imaging agent
ATE394121T1 (de) * 2001-12-28 2008-05-15 Amgen Fremont Inc Verwendung von antikörpern gegen das muc18- antigen
EP1467756A4 (de) * 2001-12-28 2007-03-21 Abgenix Inc Verfahren zur verwendung von anti-muc18-antikörpern
US20100048728A1 (en) * 2006-08-03 2010-02-25 Hy Biopharma Inc. Polycyclic dianthraquinones as inhibitors of inflammatory cytokines
WO2011139558A1 (en) 2010-05-04 2011-11-10 Hy Biopharma, Inc. Formulations and methods of treatment of skin conditions
KR102732047B1 (ko) 2016-03-01 2024-11-18 솔리제닉스, 인크. 합성 하이페리신을 생산하기 위한 시스템 및 방법

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL79661A (en) 1986-08-08 1991-01-31 Yeda Res & Dev Antiviral composition containing hypericin or pseudohypericin
IL93682A (en) 1989-03-16 1996-06-18 Yeda Res & Dev Polycyclic compounds with antigypical activity are used in the manufacture of medicines and pharmaceutical preparations containing them
JP2735609B2 (ja) * 1989-03-31 1998-04-02 協和醗酵工業株式会社 Ｕｃｎ―１０２８ｄ誘導体
IL92315A (en) 1989-11-15 1996-12-05 Yeda Res & Dev Preparation of Hypericin from Amodin Enron
US5466468A (en) 1990-04-03 1995-11-14 Ciba-Geigy Corporation Parenterally administrable liposome formulation comprising synthetic lipids
US5514714A (en) 1990-08-23 1996-05-07 New York University Methods and polycyclic aromatic compound containing compositions for treating T-cell-mediated diseases
IL104693A0 (en) 1992-02-14 1993-06-10 Yeda Res & Dev Hypericin derivatives and pharmaceutical compositions comprising them
TW235298B (de) 1992-02-27 1994-12-01 Ciba Geigy
AU5959994A (en) * 1992-12-23 1994-07-19 Iowa State University Research Foundation Inc. Molecular flashlight
US6576784B1 (en) * 1993-05-27 2003-06-10 Yeda Research And Development Co. Ltd. Antiviral agents
US5824654A (en) * 1994-09-02 1998-10-20 New York University Method for delivery of nucleic acids to cells using hypericin polyamine complexes
US5556992A (en) 1994-09-02 1996-09-17 Universite De Montreal Novel rhodamine derivatives for photodynamic therapy of cancer and in vitro purging of the leukemias

Also Published As

Publication number Publication date
CA2298820C (en) 2008-06-03
AU8355598A (en) 1999-02-22
US6229048B1 (en) 2001-05-08
DE69813828D1 (de) 2003-05-28
EP1001924B1 (de) 2003-04-23
CA2298820A1 (en) 1999-02-11
DE69813828T2 (de) 2004-03-04
IL121440A0 (en) 1998-01-04
WO1999006347A1 (en) 1999-02-11
EP1001924A1 (de) 2000-05-24

Similar Documents

Publication Publication Date Title
DE60026538D1 (de) Pharmazeutische zubereitungen die clavulansäure oder derivate enthalten zur behandlund von neurologischen störungen
Boehncke et al. Photodynamic therapy in psoriasis: suppression of cytokine production in vitro and recording of fluorescence modification during treatment in vivo
LU90718I2 (fr) Visudyne-verteporfin et ses d-riv-s pharmaceutiquement acceptables
EP0425566A4 (en) New photosensitizing agents
PT933995E (pt) Metodo para tratamento de lesao endotelial
RU93051543A (ru) Производные акридина, способ получения, фармацевтическая композиция и способ лечения злокачественных опухолей
ATE283271T1 (de) Porphyrin derivate, ihre verwendung in der photodynamischen therapie und diese enthaltende medizinische geräte
NO172344C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive substituerte flavonoidforbindelser og salter
PL333920A1 (en) 3-pyridyl enantiomers and their application as pain-relieving agents
ES2171933T3 (es) Derivados de androsteno.
DE69426334D1 (de) Parenterales Busulfan zur Behandlung von malignen Krankheiten
Berns et al. Response of psoriasis to red laser light (630 nm) following systemic injection of hematoporphyrin derivative
DE69813828D1 (de) Verwendung v0n 1,3,4,6-tetrahydroxy-helianthron und derivaten in der photodynamischen therapie und derivate
DE69202441D1 (de) Melatoninderivate und Kombinationen mit Antiestrogenen zur Behandlung von Brustkarzinoma.
BR9813318A (pt) Processo de tratamento de tumores e degeneração macular em paciente humano ou veterinário, composição farmacêutica para tratamento de tumores e degeneração macular em um paciente humano ou veterinário
DE60237993D1 (de) Derivate von isoindigo, indigo und indirubin und deren verwendung bei der behandlung von krebs
Petrozzi et al. Topical methoxsalen and blacklight in the treatment of psoriasis
ATE313334T1 (de) Behandlung von tumoren mit photodynamischer therapie
ATE216892T1 (de) Inhibitor von nebenwirkungen zur krebstherapy
Dougherty et al. Phototherapy of human tumors
DK0986393T3 (da) Anvendelse af et nitroxid eller et prodrug heraf ved profylaktisk og terapeutisk behandling af cancer
Langner et al. Dermal toxicity of 8-methoxypsoralen administered (by gavage) to hairless mice irradiated with long-wave ultraviolet light
HUT70757A (en) Pharmaceutical compositions for treating skin disorders
Lui et al. Photodynamic therapy of malignant skin tumors with Benzoporphyrin derivative-monoacid ring A (BPD-MA): preliminary observations
Tomio et al. Effect of hematoporphyrin and red light on AH-130 solid tumors in rats

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties